That’s why she and her group teamed up with machine-learning-for-chemistry expert Gabe Gomes and his group at Carnegie Mellon ...
RXRX's CDK7 inhibitor REC-617 has demonstrated activity, but additional data from the ELUCIDATE trial in various solid tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback